Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioLineRx (BLRX) Inventory Average: 2023-2025

Historic Inventory Average for BioLineRx (BLRX) over the last 1 years, with Jun 2025 value amounting to $3.1 million.

  • BioLineRx's Inventory Average fell 5.49% to $3.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.1 million, marking a year-over-year decrease of 5.49%. This contributed to the annual value of $2.5 million for FY2024, which is N/A change from last year.
  • Per BioLineRx's latest filing, its Inventory Average stood at $3.1 million for Q2 2025, which was down 4.57% from $3.2 million recorded in Q1 2025.
  • In the past 5 years, BioLineRx's Inventory Average registered a high of $3.6 million during Q3 2024, and its lowest value of $1.7 million during Q4 2023.
  • For the 3-year period, BioLineRx's Inventory Average averaged around $2.9 million, with its median value being $3.2 million (2025).
  • As far as peak fluctuations go, BioLineRx's Inventory Average surged by 102.39% in 2024, and later decreased by 5.49% in 2025.
  • Quarterly analysis of 3 years shows BioLineRx's Inventory Average stood at $1.7 million in 2023, then soared by 102.39% to $3.3 million in 2024, then fell by 5.49% to $3.1 million in 2025.
  • Its Inventory Average stands at $3.1 million for Q2 2025, versus $3.2 million for Q1 2025 and $3.3 million for Q4 2024.